Currency in INR
| Earnings estimate | Current qtr. (Dec 2018) | Next qtr. (Mar 2019) | Current year (2019) | Next year (2020) |
|---|
| No. of analysts | 0 | 0 | 0 | 0 |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low estimate | 0 | 0 | 0 | 0 |
| High estimate | 0 | 0 | 0 | 0 |
| Year ago EPS | 3.37 | 13.55 | N/A | N/A |
| Revenue estimate | Current qtr. (Dec 2018) | Next qtr. (Mar 2019) | Current year (2019) | Next year (2020) |
|---|
| No. of analysts | 2 | 2 | 27 | 27 |
| Avg. Estimate | 19.88B | 21.02B | 76.82B | 87.52B |
| Low estimate | 19.74B | 20.14B | 72.11B | 81.57B |
| High estimate | 20.02B | 21.9B | 82.36B | 96.06B |
| Year ago sales | 14.77B | 17.22B | 60.02B | 76.82B |
| Sales growth (year/est) | 34.60% | 22.10% | 28.00% | 13.90% |
| Earnings history | 31/12/2017 | 31/03/2018 | 30/06/2018 | 30/09/2018 |
|---|
| Est. EPS | 13.4 | 9.68 | 10.46 | 11.43 |
| Actual EPS | 3.37 | 13.55 | 9.66 | 10.57 |
| Difference | -10.03 | 3.87 | -0.8 | -0.86 |
| Surprise % | -74.90% | 40.00% | -7.60% | -7.50% |
| EPS trend | Current qtr. (Dec 2018) | Next qtr. (Mar 2019) | Current year (2019) | Next year (2020) |
|---|
| Current estimate | 0 | 0 | 0 | 0 |
| 7 days ago | 13.47 | 14.17 | 47.94 | 65.82 |
| 30 days ago | 13.47 | 14.17 | 47.94 | 65.82 |
| 60 days ago | 13.47 | 14.17 | 47.94 | 65.82 |
| 90 days ago | 13.47 | 14.17 | 47.94 | 65.82 |
| EPS revisions | Current qtr. (Dec 2018) | Next qtr. (Mar 2019) | Current year (2019) | Next year (2020) |
|---|
| Up last 7 days | N/A | N/A | N/A | N/A |
| Up last 30 days | N/A | 1 | N/A | N/A |
| Down last 7 days | N/A | N/A | N/A | N/A |
| Down last 30 days | N/A | N/A | N/A | N/A |
| Growth estimates | TORNTPHARM.BO | Industry | Sector(s) | S&P 500 |
|---|
| Current qtr. | N/A | N/A | N/A | N/A |
| Next qtr. | N/A | N/A | N/A | N/A |
| Current year | N/A | N/A | N/A | N/A |
| Next year | N/A | N/A | N/A | N/A |
| Next 5 years (per annum) | 34.00% | N/A | N/A | N/A |
| Past 5 years (per annum) | N/A | N/A | N/A | N/A |
